Treatment consisted of high-dose abatacept, ruxolitinib, and proactive monitoring for respiratory muscle involvement PHILADELPHIA – Among cancer patients who...
Study reports five-year survival outcomes PHILADELPHIA – Patients with resectable non-small cell lung cancer (NSCLC) who were treated with...
PHILADELPHIA – The American Association for Cancer Research (AACR) will award Carl H. June, MD, Fellow of the AACR...
Researchers identified mutational signatures characteristic of chemotherapy exposure PHILADELPHIA – Researchers identified a higher rate of clonal hematopoiesis (CH)...
American Association for Cancer Research (AACR) President Lisa M. Coussens, PhD, FAACR, issued the following statement on President Biden’s...
PHILADELPHIA — The American Association for Cancer Research (AACR) and the African Organisation for Research and Training in Cancer...
Responses to the off-the-shelf therapy were observed in 95 percent of patients PHILADELPHIA – Posoleucel, an investigational allogeneic off-the-shelf...